serevent diskus

Generic: salmeterol xinafoate

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name serevent diskus
Generic Name salmeterol xinafoate
Labeler glaxosmithkline llc
Dosage Form POWDER, METERED
Routes
ORAL RESPIRATORY (INHALATION)
Active Ingredients

salmeterol xinafoate 50 ug/1

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0521
Product ID 0173-0521_5532804f-f5b5-492b-a092-0b1ce60c8de1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020692
Listing Expiration 2026-12-31
Marketing Start 1997-11-25

Pharmacologic Class

Classes
adrenergic beta2-agonists [moa] beta2-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730521
Hyphenated Format 0173-0521

Supplemental Identifiers

RxCUI
866048 866049
UNII
6EW8Q962A5

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name serevent diskus (source: ndc)
Generic Name salmeterol xinafoate (source: ndc)
Application Number NDA020692 (source: ndc)
Routes
ORAL RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 50 ug/1
source: ndc
Packaging
  • 1 INHALER in 1 CARTON (0173-0521-00) / 60 POWDER, METERED in 1 INHALER
source: ndc

Packages (1)

Ingredients (1)

salmeterol xinafoate (50 ug/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL", "RESPIRATORY (INHALATION)"], "spl_id": "5532804f-f5b5-492b-a092-0b1ce60c8de1", "openfda": {"unii": ["6EW8Q962A5"], "rxcui": ["866048", "866049"], "spl_set_id": ["12d9728e-6b5c-4aee-bfb0-745e542ed2e4"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INHALER in 1 CARTON (0173-0521-00)  / 60 POWDER, METERED in 1 INHALER", "package_ndc": "0173-0521-00", "marketing_start_date": "19971125"}], "brand_name": "SEREVENT DISKUS", "product_id": "0173-0521_5532804f-f5b5-492b-a092-0b1ce60c8de1", "dosage_form": "POWDER, METERED", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0173-0521", "generic_name": "salmeterol xinafoate", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SEREVENT", "brand_name_suffix": "DISKUS", "active_ingredients": [{"name": "SALMETEROL XINAFOATE", "strength": "50 ug/1"}], "application_number": "NDA020692", "marketing_category": "NDA", "marketing_start_date": "19971125", "listing_expiration_date": "20261231"}